Although NEXN variants have not previously been described in cases of complex congenital heart disease, such as TGA, gain-of-function NEXN variants resulting in GATA4 suppression have been described as the cause of secundum atrial septal defects in both mouse models and humans [15]. This evidence concerns the gene NEXN and congenital heart disease.